Boston start­up lands $28M, clos­es small biotech buy­out; New longevi­ty fund takes shape

Boston-based start­up DermBiont has gone back to the ven­ture well while tack­ing on an­oth­er small buy­out to swell the clin­i­cal pipeline.

The start­up, which raised …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER